Endothelin and isoprenaline co-stimulation causes contractile failure in engineered heart tissue which is partially reversed by MEK inhibition
Zolk, O.; Muenzel, F.; Eschenhagen, T.
European Heart Journal 23(Abstract Suppl): 674
2002
ISSN/ISBN: 0195-668X Accession: 034852275
Article/Abstract emailed within 1 workday
Payments are secure & encrypted
References
Münzel, F.; Mühlhäuser, U.; Zimmermann, W.-H.; Didié, M.; Schneiderbanger, K.; Schubert, P.; Engmann, S.; Eschenhagen, T.; Zolk, O. 2005: Endothelin-1 and isoprenaline co-stimulation causes contractile failure which is partially reversed by MEK inhibition Cardiovascular Research 68(3): 464-474Zimmermann, W.H.; Endress, B.; Eschenhagen, T. 2003: Concerted growth factor stimulation induces a heart failure phenotype in engineered heart tissue Naunyn-Schmiedeberg's Archives of Pharmacology 367(Suppl 1): R92
Shen, Y.T.; Eng, W.S.; Bolduc, D.; Lynch, J.J. 1998: Inhibition of sympathetic nerve activity partially preserves LV contractile function early in development of heart failure in conscious pigs Circulation 98(17): I159
Radke, M.H.; Badillo-Lisakowski, V.; Britto-Borges, T.; Kubli, D.A.; Jüttner, R.é; Parakkat, P.; Carballo, J.L.; Hüttemeister, J.; Liss, M.; Hansen, A.; Dieterich, C.; Mullick, A.E.; Gotthardt, M. 2021: Therapeutic inhibition of RBM20 improves diastolic function in a murine heart failure model and human engineered heart tissue Science Translational Medicine 13(622): Eabe 8952
Harding, S.E.; Hunt, N.A.; Jones, S.M.; O'gara P.; Poole Wilson, P.A. 1990: Correlation between contractile response to isoprenaline in human left ventricular myocytes and indicators of heart failure Journal of Molecular and Cellular Cardiology 22(Suppl 3): S94
Clavell, A.L.; Mattingly, M.M.; Nir, A.; Aarhus, L.L.; Heublein, D.M.; Burnett, J.C.Jr 1994: Angiotensin converting enzyme inhibition modulates circulating and tissue endothelin activity in experimental heart failure Circulation 90(4 Part 2): I452
Herzig, J.W.; Gerber, W.; Salzmann, R. 1987: Heart failure and Ca++ activation of the cardiac contractile system: hereditary cardiomyopathy in hamsters (BIO 14.6), isoprenaline overload and the effect of APP 201-533 Basic Research in Cardiology 82(4): 326-340
Gross, P.; Ketteler, M.; Hensen, J.; Schömig, A.; Rascher, W. 1991: Advanced heart failure: possible role of endothelin for renal failure; baroreceptor mechanism of vasopressin (AVP) stimulation in advanced heart failure and hyponatremia Zeitschrift für Kardiologie 80(Suppl 8): 99-100
Cheng, C.P.; Suzuki, M. 1997: The role and mechanism of endothelin-1 on cardiac contractile performance in heart failure Journal of Molecular and Cellular Cardiology 29(6): A180
Xu, M.; Ji, H.; Dai, D.-Z.; Tang, X.-Y.; Dai, Y. 2008: Protective effect of the endothelin antagonist CPU0213 against isoprenaline-induced heart failure by suppressing abnormal expression of leptin, calcineurin and SERCA2a in rats Journal of Pharmacy and Pharmacology 60(6): 739-745
Sakai, S.; Miyauchi, T.; Sakurai, T.; Yamaguchi, I.; Kobayashi, M.; Goto, K.; Sugishita, Y. 1996: Pulmonary hypertension caused by congestive heart failure is ameliorated by long-term application of an endothelin receptor antagonist. Increased expression of endothelin-1 messenger ribonucleic acid and endothelin-1-like immunoreactivity in the lung in congestive heart failure in rats Journal of the American College of Cardiology 28(6): 1580-1588
Love, M.P.; Haynes, W.G.; Gray, G.A.; Webb, D.J.; McMurray, J.J. 1996: Vasodilator effects of endothelin-converting enzyme inhibition and endothelin ETA receptor blockade in chronic heart failure patients treated with ACE inhibitors Circulation 94(9): 2131-2137
Mannhardt, I.; Breckwoldt, K.; Letuffe-Brenière, D.; Schaaf, S.; Schulz, H.; Neuber, C.; Benzin, A.; Werner, T.; Eder, A.; Schulze, T.; Klampe, B.; Christ, T.; Hirt, M.N.; Huebner, N.; Moretti, A.; Eschenhagen, T.; Hansen, A. 2016: Human Engineered Heart Tissue: Analysis of Contractile Force Stem Cell Reports 7(1): 29-42
Li, H.; Sundaram, S.; Hu, R.; Lou, L.; Sanchez, F.; McDonald, W.; Agarwal, A.; Chen, C.S.; Bifano, T.G. 2023: Dynamic Control of Contractile Force in Engineered Heart Tissue IEEE Transactions on Bio-Medical Engineering 70(7): 2237-2245
Zolk, O.; Muehlhaeuser, U.; Muenzel, F.; Laufs, U.; Eschenhagen, T. 2002: Atorvastatin impairs contractile function in engineered heart tissue European Heart Journal 23(Abstract Suppl): 542
Cleland, J.G.F.; Teerlink, J.R.; Davison, B.A.; Shoaib, A.; Metra, M.; Senger, S.; Milo, O.; Cotter, G.; Bourge, R.C.; Parker, J.D.; Jondeau, G.; Krum, H.; O'Connor, C.M.; Torre-Amione, G.; van Veldhuisen, D.J.; McMurray, J.J.V. 2017: Measurement of troponin and natriuretic peptides shortly after admission in patients with heart failure-does it add useful prognostic information? An analysis of the Value of Endothelin Receptor Inhibition with Tezosentan in Acute heart failure Studies (VERITAS) European Journal of Heart Failure 19(6): 739-747
Sondergaard, C.S.; Mathews, G.; Wang, L.; Jeffreys, A.; Sahota, A.; Wood, M.; Ripplinger, C.M.; Si, M.-S. 2012: Contractile and electrophysiologic characterization of optimized self-organizing engineered heart tissue Annals of Thoracic Surgery 94(4): 1241-1248; Discussion 1249
Svane Sondergaard, C.; Mathews, G.; Lianguo, W.A.N.G.; Jeffreys, A.; Sahota, A.; Wood, M.; Ripplinger, C.M.; Si, M.S. 2012: Contractile and Electrophysiologic Characterization of Optimized Self-Organizing Engineered Heart Tissue The Annals of Thoracic Surgery 94(4): 1241-1248
Stoehr, A.; Neuber, C.; Baldauf, C.; Vollert, I.; Friedrich, F.W.; Flenner, F.; Carrier, L.; Eder, A.; Schaaf, S.; Hirt, M.N.; Aksehirlioglu, B.ül.; Tong, C.W.; Moretti, A.; Eschenhagen, T.; Hansen, A. 2014: Automated analysis of contractile force and Ca2+ transients in engineered heart tissue American Journal of Physiology. Heart and Circulatory Physiology 306(9): H1353-H1363